Hydralazine/isosorbide dinitrate
id:
hydralazine-isosorbide-dinitrate-232-8865471
title:
Hydralazine/isosorbide dinitrate
text:
Hydralazine/isosorbide dinitrate, sold under the brand name Bidil, is a fixed-dose combination medication used to treat self-identified Black people with congestive heart failure. It is a combination of hydralazine hydrochloride and isosorbide dinitrate. The American Food and Drug Administration (FDA) approved this race-specific medication to treat congestive heart failure in specifically self-identified Black patients. It provoked controversy as the first drug approved by the FDA marketed for a
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Hydralazine/isosorbide_dinitrate
date created:
date modified:
2023-11-27T16:10:07Z
main entity:
{"identifier":"Q15409422","url":"https://www.wikidata.org/entity/Q15409422"}
image:
fields total:
13
integrity:
14